GLOBULIN,HEPATITIS B IMMUNE
Price to win
From deduped DIBBS award lines (unit cost × quantity). Not a bid recommendation — observed history only.
Average unit cost
$969.84
Weighted average
$965.41
Weighted by quantity
Observed range
$930–$1,054
Coverage
20 awards
Oct 20, 2022 – Dec 11, 2024
Average: $969.84 · Weighted avg: $965.41 · Range: $930.00–$1,054.00 · Based on 20 awards, Oct 20, 2022–Dec 11, 2024.
Unit cost by award date · 20 priced lines
DIBBS award history
Distinct award lines for this NSN (deduped). Line total is unit cost × quantity.
20 distinct award lines
| Date | Manufacturer | Qty × unit | Total | Contract |
|---|---|---|---|---|
| Dec 11, 2024 | 0AG09SZY HOLDINGS, LLCBROOKLYN, NYSAM | 1 × $930.00 | $930 | SPE2DP25V0508 |
| Oct 9, 2024 | 0ZSM5NAR MEDICAL DEPOT, LLCGREER, SCSAM | 1 × $932.00 | $932 | SPE2DP25V0070 |
| Jul 8, 2024 | 0AG09SZY HOLDINGS, LLCBROOKLYN, NYSAM | 1 × $934.00 | $934 | SPE2DP24V1899 |
| May 14, 2024 | 1WAS9CENMED ENTERPRISES INCNEW BRUNSWICK, NJSAM | 4 × $930.00 | $3,720 | SPE2DP24V1478 |
| May 8, 2024 | 0ZSM5NAR MEDICAL DEPOT, LLCGREER, SCSAM | 1 × $937.70 | $938 | SPE2DP24V1435 |
| May 2, 2024 | 0AG09SZY HOLDINGS, LLCBROOKLYN, NYSAM | 2 × $938.00 | $1,876 | SPE2DP24V1422 |
| Mar 15, 2024 | 0AG09SZY HOLDINGS, LLCBROOKLYN, NYSAM | 1 × $938.00 | $938 | SPE2DP24V1084 |
| Feb 12, 2024 | 0AG09SZY HOLDINGS, LLCBROOKLYN, NYSAM | 1 × $940.00 | $940 | SPE2DP24V0793 |
| Feb 5, 2024 | 0ZSM5NAR MEDICAL DEPOT, LLCGREER, SCSAM | 1 × $943.00 | $943 | SPE2DP24P0279 |
| Feb 5, 2024 | 0ZSM5NAR MEDICAL DEPOT, LLCGREER, SCSAM | 1 × $943.00 | $943 | SPE2DP24P0280 |
| Nov 20, 2023 | 0AG09SZY HOLDINGS, LLCBROOKLYN, NYSAM | 1 × $1,054.00 | $1,054 | SPE2DP24V0239 |
| Jun 21, 2023 | 0AG09SZY HOLDINGS, LLCBROOKLYN, NYSAM | 1 × $1,033.00 | $1,033 | SPE2DP23V1791 |
| Jun 7, 2023 | 3W8H0MR UNLIMITED, LLCBRENHAM, TXSAM | 1 × $1,034.00 | $1,034 | SPE2DP23V1683 |
| Apr 10, 2023 | 0AG09SZY HOLDINGS, LLCBROOKLYN, NYSAM | 5 × $1,036.00 | $5,180 | SPE2DP23V1231 |
| Feb 10, 2023 | 0AG09SZY HOLDINGS, LLCBROOKLYN, NYSAM | 1 × $1,034.00 | $1,034 | SPE2DP23V0732 |
Manufacturers who have won this NSN
Distinct CAGEs with a confirmed DIBBS award line for this part — each opens the manufacturer page.
Approved manufacturers
Qualified to supply per MCRL — no confirmed DIBBS award on record for this NSN. Each CAGE opens the manufacturer page.
PN 6505NCM093873
PN 14052
PN NDC69800-4203-01, NDC69800-4203-02
Characteristics
FLIS item characteristics from PUB LOG identification.
| Characteristic | Value |
|---|---|
| MEDICAL DESIGNATION AND GRADE | UNITED STATES PHARMACOPEIA |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | HEPATITIS B IMMUNE GLOBULIN NABI-HB SD VIAL 5ML |
| PROTECTIVE STORAGE FEATURE | REQUIRES REFRIGERATION STORAGE BETWEEN 2 TO 8 DEG CELSIUS AND SUBJECT TO DAMAGE BY FREEZING |
| SPECIAL FEATURES | 1560 INTERNATIONAL UNITS PER 5ML ACTIVE INGREDIENTS; 5ML SINGLE DOSE VIAL; FOR IM USE; FOR THE TREATMENT OF ACUTE EXPOSURE TO BLOOD CONTAINING HEPATITIS B; A HYPERIMMUNE GLOBULIN (HUMAN). REQUIRES REFRIGERATION 2 C TO 8 C (36 F TO 46 F) SUBJECT TO DAMAGE BY FREEZING. |
Open buys
DIBBS · quotes by Sep 17, 2026 · UNRESTRICTED
